Goldman Sachs’s Veradigm Inc. Common Stock MDRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-362,020
| Closed | -$2.79M | – | 6067 |
|
|
2024
Q1 | $2.79M | Sell |
362,020
-1,234,664
| -77% | -$11.2M | ﹤0.01% | 3606 |
|
|
2023
Q4 | $16.7M | Buy |
1,596,684
+99,528
| +7% | +$1.22M | ﹤0.01% | 2071 |
|
|
2023
Q3 | $19.7M | Sell |
1,497,156
-232,052
| -13% | -$3.04M | ﹤0.01% | 1812 |
|
|
2023
Q2 | $21.8M | Sell |
1,729,208
-535,028
| -24% | -$6.5M | ﹤0.01% | 1769 |
|
|
2023
Q1 | $29.5M | Buy |
2,264,236
+63,335
| +3% | +$1.03M | 0.01% | 1459 |
|
|
2022
Q4 | $38.8M | Sell |
2,200,901
-371,978
| -14% | -$6.23M | 0.01% | 1380 |
|
|
2022
Q3 | $39.2M | Sell |
2,572,879
-283,587
| -10% | -$4.59M | 0.01% | 1289 |
|
|
2022
Q2 | $42.4M | Sell |
2,856,466
-19,061
| -0.7% | -$356K | 0.01% | 1244 |
|
|
2022
Q1 | $64.8M | Sell |
2,875,527
-551,568
| -16% | -$11.2M | 0.01% | 1070 |
|
|
2021
Q4 | $63.2M | Buy |
3,427,095
+469,894
| +16% | +$7.46M | 0.01% | 1147 |
|
|
2021
Q3 | $39.5M | Sell |
2,957,201
-56,034
| -2% | -$905K | 0.01% | 1467 |
|
|
2021
Q2 | $55.8M | Buy |
3,013,235
+705,267
| +31% | +$11.9M | 0.01% | 1158 |
|
|
2021
Q1 | $34.7M | Sell |
2,307,968
-32,541
| -1% | -$521K | 0.01% | 1464 |
|
|
2020
Q4 | $33.8M | Sell |
2,340,509
-154,924
| -6% | -$1.88M | 0.01% | 1436 |
|
|
2020
Q3 | $20.3M | Sell |
2,495,433
-213,607
| -8% | -$1.75M | 0.01% | 1721 |
|
|
2020
Q2 | $18.3M | Buy |
2,709,040
+132,040
| +5% | +$856K | 0.01% | 1752 |
|
|
2020
Q1 | $18.1M | Sell |
2,577,000
-2,873,358
| -53% | -$23.3M | 0.01% | 1585 |
|
|
2019
Q4 | $53.5M | Sell |
5,450,358
-636,755
| -10% | -$6.71M | 0.01% | 1094 |
|
|
2019
Q3 | $66.8M | Sell |
6,087,113
-1,571,330
| -21% | -$16.1M | 0.02% | 903 |
|
|
2019
Q2 | $89.1M | Buy |
7,658,443
+690,013
| +10% | +$7.01M | 0.03% | 747 |
|
|
2019
Q1 | $66.5M | Sell |
6,968,430
-903,733
| -11% | -$9.98M | 0.02% | 910 |
|
|
2018
Q4 | $75.9M | Buy |
7,872,163
+406,433
| +5% | +$4.53M | 0.02% | 771 |
|
|
2018
Q3 | $106M | Sell |
7,465,730
-2,574,135
| -26% | -$35M | 0.03% | 720 |
|
|
2018
Q2 | $120M | Buy |
10,039,865
+2,378,490
| +31% | +$29.3M | 0.03% | 620 |
|
|
2018
Q1 | $94.6M | Sell |
7,661,375
-177,766
| -2% | -$2.53M | 0.02% | 803 |
|
|
2017
Q4 | $114M | Sell |
7,839,141
-1,173,190
| -13% | -$16.3M | 0.03% | 735 |
|
|
2017
Q3 | $128M | Buy |
9,012,331
+1,724,694
| +24% | +$22.3M | 0.03% | 663 |
|
|
2017
Q2 | $93M | Buy |
7,287,637
+4,830,374
| +197% | +$58.7M | 0.02% | 817 |
|
|
2017
Q1 | $31.2M | Buy |
2,457,263
+1,242,181
| +102% | +$14.7M | 0.01% | 1570 |
|
|
2016
Q4 | $12.4M | Sell |
1,215,082
-2,546,745
| -68% | -$29.1M | ﹤0.01% | 2298 |
|
|
2016
Q3 | $49.5M | Sell |
3,761,827
-609,824
| -14% | -$8.16M | 0.02% | 1213 |
|
|
2016
Q2 | $55.5M | Sell |
4,371,651
-1,484,695
| -25% | -$19.7M | 0.02% | 1045 |
|
|
2016
Q1 | $77.4M | Buy |
5,856,346
+1,173,759
| +25% | +$15.4M | 0.03% | 805 |
|
|
2015
Q4 | $72M | Sell |
4,682,587
-1,201,283
| -20% | -$17.2M | 0.02% | 862 |
|
|
2015
Q3 | $73M | Sell |
5,883,870
-10,050,766
| -63% | -$138M | 0.02% | 806 |
|
|
2015
Q2 | $218M | Sell |
15,934,636
-5,818,240
| -27% | -$78.6M | 0.07% | 320 |
|
|
2015
Q1 | $260M | Buy |
21,752,876
+5,465,278
| +34% | +$66.8M | 0.08% | 256 |
|
|
2014
Q4 | $208M | Buy |
16,287,598
+7,931,567
| +95% | +$101M | 0.07% | 349 |
|
|
2014
Q3 | $112M | Sell |
8,356,031
-605,691
| -7% | -$9.18M | 0.04% | 585 |
|
|
2014
Q2 | $144M | Buy |
8,961,722
+1,484,549
| +20% | +$23.1M | 0.05% | 494 |
|
|
2014
Q1 | $135M | Sell |
7,477,173
-492,834
| -6% | -$8.53M | 0.04% | 477 |
|
|
2013
Q4 | $123M | Buy |
7,970,007
+1,438,662
| +22% | +$21.2M | 0.04% | 540 |
|
|
2013
Q3 | $97.1M | Sell |
6,531,345
-751,914
| -10% | -$11.3M | 0.04% | 611 |
|
|
2013
Q2 | $94.2M | Buy |
+7,283,259
| New | +$97.6M | 0.04% | 580 |
|
Other funds holding MDRX
MCM
KCM
TRSOTSOK
IC
GI
FRA
SWM
HNB
Goldman Sachs's MDRX Position: Q2 2024 in Review
Goldman Sachs sold out of Veradigm Inc. Common Stock (MDRX) in Q2 2024, closing a stake of 362,020 shares — an estimated $2.79M sold.
Goldman Sachs first reported a position in MDRX in Q2 2013 and held it in 44 quarters. The position peaked at $260M in Q1 2015. 10 funds tracked by Wall St. Rank hold MDRX as of Q2 2024.
- Goldman Sachs reported no remaining Veradigm Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Goldman Sachs sold 362,020 Veradigm Inc. Common Stock shares in Q2 2024, an estimated $2.79M.
- Goldman Sachs first reported a position in Veradigm Inc. Common Stock in Q2 2013 and held it in 44 quarters.
- Goldman Sachs's Veradigm Inc. Common Stock position peaked at $260M in Q1 2015.
- 10 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q2 2024.
Based on Goldman Sachs's 13F filing for Q2 2024, filed 13 Aug 2024.